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Infectious bronchitis virus (IBV) replicates in the epithelial cells of trachea and lungs of chicken, however
the mechanism of generation of innate immune response against IBV infection in these tissues has not
been fully characterized. Our objective was to study innate responses induced early following IBV
infection in chickens. Initiation of the transcription of selected innate immune genes such as TLR3, TLR7,
MyD88, IL-1β and IFN-β, as well as recruitment of macrophages, were evident following an initial down
regulation of some of the observed genes (TLR3, IL-1β, and IFN-γ) in trachea and lung. This initial down-
regulation followed by the induction of innate immune response to IBV infection appears to be
inadequate for the control of IBV genome accumulation and consequent histopathological changes in
these tissues. Potential induction of innate immunity before infection occurs may be necessary to reduce
the consequences since vaccine induced immunity is slow to develop.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Infectious bronchitis virus (IBV) is a positive sense RNA virus
that belongs to the Family Coronaviridae. IBV primarily targets the
epithelial cells of the respiratory, urinary and reproductive tracts
in the domestic chicken (Gallus gallus domesticus) (Cavanagh,
2007; Cavanagh et al., 1997; Cook et al., 2012), results pathogenic
processes with mortality rates as high as 30% in chicks less than
4 weeks old and egg production loss in layers. The ability of IBV to
infect different organ systems depends on the strain of the virus.
For example, infection with the Connecticut (Conn) A5968 strain
of IBV is limited to replication in the respiratory tract of chickens
(Cavanagh, 2005; Uenaka et al., 1998) and the virus is transmitted
between individuals through the shedding of viral particles in the
nasal and ocular discharge of infected birds (Cook et al., 2012).
For the control of disease caused by IBV, live attenuated viral
vaccines are available and had so far been very reliable (Cavanagh,
2003, 2007). These vaccines use IBV strains such as Massachusetts,
Connecticut and Arkansas and combinations thereof providing
protection against almost all ﬁeld strains of IBV. However, emer-
gence of new variant more heterogeneous IBV strains (Cavanagh,
2003), leads to infectious bronchitis outbreaks in vaccinated ﬂocks
leading to signiﬁcant production losses (Shimazaki et al., 2009;
Xu et al., 2007). Therefore a novel approach that could be used as
an alternative or additional to the existing means of control is
urgently needed. One such approach may be the use of innate
immune mediators to empower the innate immune system.
The innate and adaptive immune responses to viral infection in
chickens are interconnected, with the innate or non-speciﬁc
response being the more rapid of the two. Immune cells and cells
on the mucosal surface are involved in innate immune responses
and recognize pathogen associated molecular patterns (PAMPs).
PAMPs are generally conserved between the different types of
pathogens, but are not expressed by the host cells, and can be
recognized by the host cell through membrane associated and
intra-cellular toll-like receptors (TLRs) (Akira, 2001). Among TLRs,
TLR3 and TLR7 are well known for recognition of RNA virus
encoded PAMPs (Akira, 2001). In chickens, TLR3 and TLR7 are
orthhologous to their mammalian counterparts (Kannaki et al.,
2010). TLR3 recognizes and binds to the double-stranded (ds)RNA
intermediates produced during viral replication (Alexopoulou
et al., 2001; Higgs et al., 2006; Iqbal et al., 2005) Stimulation of
TLR3 leads to activation of TIR-domain-containing adapter-
inducing interferon-β (TRIF) adaptor protein-mediated pathway,
whereas TLR7 responds to single-stranded (ss)RNA produced
during intracellular viral replication, activating the myeloid differ-
entiation primary response gene 88 (MyD88) mediated-pathway
(Akira, 2001; Watters et al., 2007). The end products of both TLR3
and TLR7 signaling pathways are the production of anti-viral type I
interferon (IFN)-α and -β, and pro-inﬂammatory cytokines,
respectively (Guillot et al., 2005). Interleukin (IL)-1β plays an
important role in chemotaxis, stimulating the cellular response
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and recruiting cells, such as macrophages, to the site of infection
(Babcock et al., 2008). Macrophages are important cells of the
innate immune response; their functional roles include phagocy-
tosis of foreign material, cytokine and chemokine secretion, and
the presentation of antigens to help facilitate the development of
antigen-speciﬁc adaptive immune responses (Mast et al., 1998;
Qureshi et al., 2000; Tate et al., 2010). Macrophages are also source
of nitric oxide (NO) production, which is the product of the activity
of inducible nitric oxide synthase (iNOS) in defence against
microbial infections (Ariaans et al., 2008; Ficken et al., 1987;
Naqi et al., 2001; Read, 1999).
Host responses in the trachea following intranasal immuniza-
tion of chickens using IBV vaccine strains such as attenuated or
non-attenuated Massachusetts (Mass) IBV have been studied (Guo
et al., 2008; Wang et al., 2006). These studies have shown an
increase in the mRNA expression of TLR2, TLR3, TLR6, TLR7, IL-1β,
and genes involved in IFN signaling among a number of other
genes following IBV immunization. It is not known whether the
host responses are elicited against any IBV strain in lung, although
the lung is also a target organ for IBV. The nature and extent of the
innate host responses elicited against virulent IBV strains in the
trachea and lung are also not known. It has also been shown that
following immunization with the IBV Mass41 strain that the
number of macrophages in bronchoalvelar lavage ﬂuid is increased
(Fulton et al., 1990; Fulton et al., 1993). However, it is not known
whether these macrophages are mobilized from the trachea, lung,
or both tissues in response to IBV infection.
Our main hypothesis is that IBV infection will result in
increases in macrophage numbers and relative mRNA expression
of innate host response genes in respiratory tissues early following
infection. Therefore, the objective of our investigation was to
characterize the host innate response in terms of the expression
of TLRs, type I and II IFNs, and pro-inﬂammatory cytokine genes, as
well as any changes in macrophage numbers within the lungs and
trachea early during infection with IBV. In this study, we saw an
up-regulation of TLR3 and TLR7 mRNA and increased macrophage
numbers in the trachea and lung, as well as an up-regulation of
IFNβ, and IL-1β mRNA expression in trachea that indicated the
initiation of innate host responses. Conversely, we also observed
an initial down regulation of mRNA expression of genes, namely
TLR3, IL-1β, and IFN-γ. This early delay in the induction of innate
host responses following the infection may be associated with an
increase in the IBV genome load and histological changes in
trachea and lungs of IBV infected chickens.
Results
Clinical and pathological observations
Uninfected chickens showed no clinical signs, gross or histolo-
gical lesions. Although all the IBV infected chickens did not
develop respiratory signs, they all showed non-speciﬁc signs such
as huddling together under the lamp and droopy wings. The
infected chickens though did not show any gross lesions in the
respiratory tract, histological changes were evident in both trachea
and lungs. In the trachea, we saw a signiﬁcant increase in the
pathology over time, with the highest scores evident at 72 hpi for
IBV infected tissues when compared to all other time points
(po0.0001, data not shown). For lung, there were also signiﬁcant
increases in the histopathological scores overtime, but only when
comparing the various IBV infected tissues to the uninfected
controls at time points 12, 48, and 72 hpi (po0.0001, data not
shown).
Trachea Lung
*
*
**
*
m
R
N
A
 E
xp
re
ss
io
n 
(I
nf
ec
te
d 
G
ro
up
/C
on
tr
ol
 G
ro
up
) 
Fig. 1. Relative TLR3 and TLR7 mRNA expression in trachea and lungs of chickens infected with the Conn A5968 strain of IBV. (A) and (B) represent relative TLR3 and TLR7
mRNA expression in trachea, respectively. (C) and (D) represent TLR3 and TLR7 mRNA expression in the lung, respectively. Chickens were infected intra-tracheally with the
Conn A5968 strain of IBV at 6 days of age and trachea and lung tissues were collected at 12, 24, 48, and 72 h post-infection (hpi). There were ﬁve IBV-infected chickens at
each time point (six animals were sampled at 12 hpi) and ﬁve PBS-treated chickens used as controls for each time point (only two animals were sampled at 72 hpi for the
control group). Target mRNA expression was normalized via the geometrical mean of Eff.(uninfected control)Cp for all control genes (β-actin and ubiquitin). Error bars
represent standard error of the mean (SEM). n¼relative mRNA expression is signiﬁcantly up-regulated when compared to the uninfected controls and nn¼relative mRNA
expression is signiﬁcantly down-regulated when compared to controls.
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IBV genome load in trachea and lungs
The viral genome load in the trachea and lung was measured
using the complementary DNA (cDNA) originating from RNA
extracted from IBV-infected chickens by analysis with real-time
quantitative polymerase chain reaction (qPCR). The IBV genome
load was signiﬁcantly higher in the trachea at only 72 hpi
(p¼0.013) when compared to 12 or 48 hpi due to higher varia-
bility among individual birds within the group (data not shown).
Conversely, there was no signiﬁcant difference recorded between
time points for IBV genome loads measured within the lungs
(p¼0.176, data not shown).
Expression of mRNA of TLR3 and TLR7 in the trachea and lungs
The mRNA expression data for TLR3 and TLR7 in the trachea are
illustrated in Fig. 1A and B, respectively. The TLR3 mRNA expres-
sion in the trachea was signiﬁcantly down-regulated at 12 hpi
(p¼0.033) and signiﬁcantly up-regulated at 72 hpi (p¼0.010)
when comparing the IBV infected groups to the uninfected
controls. At 24 and 48 hpi, there was no signiﬁcant difference in
the TLR3 mRNA expression in the trachea when comparing IBV
infected groups to the control groups (24 hpi, p¼0.424; 48 hpi,
p¼0.565). Conversely, TLR7 mRNA expression in the trachea was
signiﬁcantly up-regulated when compared to the controls at
24 hpi (p¼0.001). At 12, 48, and 72 hpi, there was no signiﬁcant
difference in TLR7 mRNA expression in the trachea when compar-
ing IBV infected groups to the control groups (12 hpi, p¼0.739;
48 hpi, p¼0.217; 72 hpi, p¼0.970).
The mRNA expression data for TLR3 and TLR7 in lung are
illustrated in Fig. 1C and D, respectively. The TLR3 mRNA expres-
sion in lung was signiﬁcantly up-regulated at 24 hpi (p¼0.017).
In comparison, at 12, 48, and 72 hpi there was no signiﬁcant
difference in TLR3 mRNA levels in trachea when comparing IBV
infected groups to the controls (12 hpi, p¼0.237; 48 hpi, p¼0.606;
72 hpi, p¼0.917). There were no signiﬁcant changes in TLR7 mRNA
expression in the lung at any of the time points when comparing
IBV infected groups to the control group (12 hpi, p¼0.563; 24 hpi,
p¼0.205; 48 hpi, p¼0.641; 72 hpi, p¼0.730).
Expression of mRNA of MyD88 and TRIF in lung and trachea
The mRNA expression data for MyD88 in the trachea and lungs
are illustrated in Fig. 2A and B, respectively. The MyD88 mRNA
expression in trachea was signiﬁcantly up-regulated at 24 hpi
(p¼0.022), but there was no signiﬁcant change in expression
levels at 12, 48, or 72 hpi (12 hpi, p¼0.922; 48 hpi, p¼0.337;
72 hpi, p¼0.535). There was no signiﬁcant change in MyD88
mRNA expression in lung for any of the time points (12 hpi,
p¼0.652; 24 hpi, p¼0.896; 48 hpi, p¼0.774; 72 hpi, p¼0.893).
There was no signiﬁcant change in TRIF mRNA expression in
the trachea and lung at any of the time points (data not shown).
Expression of mRNA of genes of interferons, pro-inﬂammatory
cytokines, and iNOS in trachea and lung
The mRNA expression data for IL-1β, IFN-β, and IFN-γ in
trachea are illustrated in Fig. 3A–C, respectively. A signiﬁcant
down-regulation of IL-1β mRNA expression was observed at
12 hpi (p¼0.013), as well as a signiﬁcant up-regulation at 72 hpi
(p¼0.006). No signiﬁcant change in IL-1β mRNA expression at 24
or 48 hpi was observed (24 hpi, p¼0.905; 48 hpi, p¼0.297). For
IFN-β mRNA expression, a signiﬁcant up-regulation was observed
at 24 hpi (p¼0.004), with no other signiﬁcant changes observed at
the other time points (12 hpi, p¼0.230; 48 hpi, p¼0.151; 72 hpi,
p¼0.869). Expression of IFN-γ mRNA was also seen to have a
signiﬁcant down-regulation at 12 hpi (p¼0.009) and a trend
towards up-regulation by 24 hpi. However, there were no signiﬁ-
cant changes at any of the other time points (24 hpi, p¼0.052;
48 hpi, p¼0.220; 72 hpi, p¼0.923).
The mRNA expression data for IL-1β, IFN-β, and IFN-γ in lung
are illustrated in Fig. 3D–F, respectively. There was no signiﬁcant
change in IL-1βmRNA expression in lung at any of the time points
(12 hpi, p¼0.666; 24 hpi, p¼0.439; 48 hpi, p¼0.964; 72 hpi,
p¼0.803). IFN-β mRNA expression was found to have no signiﬁ-
cant changes at any of the time points as well (12 hpi, p¼0.802;
24 hpi, p¼0.283; 48 hpi, p¼0.444; 72 hpi, p¼0.209). Finally, IFN-γ
mRNA expression was seen to have the same pattern as the other
preceding genes measured in the lung, as there was no signiﬁcant
change at any of the time points (12 hpi, p¼0.267; 24 hpi,
p¼0.446; 48 hpi, p¼0.996; 72 hpi, p¼0.821).
There was no signiﬁcant change in iNOS and IFN-α mRNA
expression in trachea and lung at any of the time points (data not
shown).
Quantiﬁcation of macrophages present in trachea and lungs
Fig. 4 illustrates the difference in the percentage of macro-
phages present in the trachea and lungs of control and IBV infected
chickens. The percentage of macrophages present in the repre-
sentative FACS plots from tracheal samples collected from control
and IBV infected chickens at 24 hpi are illustrated in Fig. 4A and B
respectively. It was observed that macrophage numbers in the
trachea only signiﬁcantly increased in IBV infected chickens at
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Fig. 2. Relative MyD88 mRNA expression in trachea and lungs of chickens infected with the Conn A5968 strain of IBV. (A) and (B) represent relative MyD88 mRNA expression
in trachea and lung, respectively. Experimental design was as indicated in the legend of Fig. 1. Target mRNA expression was normalized via the geometrical mean of Eff.
(uninfected control)Cp for all control genes (β-actin and ubiquitin). Error bars represent SEM. n¼relative mRNA expression is signiﬁcantly up-regulated when compared to
the uninfected controls.
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24 hpi when compared to control chickens (po0.0001). The
percentage of macrophages present in the representative FACS
plots from lungs of control and IBV infected chickens at 24 hpi are
illustrated in Fig. 4D and E respectively. The only signiﬁcant
increase in the percentage of macrophages in IBV infected lung
tissues when compared to the control was seen at 24 hpi
(p¼0.002). Fig. 4C and F provides quantitative data to show the
difference between the IBV infected groups and the uninfected
control groups in terms of the percentage of macrophages at each
time point for the trachea and lung, respectively.
**
** **
Trachea
Lung
m
R
N
A
 E
xp
re
ss
io
n 
(I
nf
ec
te
d 
G
ro
up
/C
on
tr
ol
 G
ro
up
) 
Fig. 3. Relative IL-1β, IFN-β and -γmRNA expression in trachea and lungs of chickens infected with the Conn A5968 strain of IBV. (A–C) represents relative IL-1β, IFN-β, and -γ
mRNA expression in trachea, respectively. (D–F) represents relative IL-1β, IFN-β, and -γ mRNA expression in the lung, respectively. Experimental design was as indicated in
the legend of Fig. 1. Target mRNA expression was normalized via the geometrical mean of Eff.(uninfected control)Cp for all control genes (β-actin and ubiquitin). Error bars
represent SEM. n¼relative mRNA expression is signiﬁcantly up-regulated when compared to the uninfected controls, and nn¼relative mRNA expression is signiﬁcantly
down-regulated when compared to uninfected controls.
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Fig. 4. Quantiﬁcation of macrophages present in trachea and lung. Chickens were infected intra-tracheally with Conn A5968 at 6 days of age and trachea and lung tissues
were collected at 12, 24, and 48 hpi. There were three IBV-infected and three PBS-treated chickens used at each time point for the lung macrophage quantiﬁcation, and in a
separate experiment with the same experimental design, four IBV-infected and ﬁve PBS-treated chickens used at each time point for quantiﬁcation of macrophages in
trachea. (A) and (B) represent the percent of macrophages in control and IBV infected trachea respectively at 24 hpi. (D) and (E) represent the percent of macrophages in IBV
infected and control lung respectively for 24 hpi. (C) and (F) are graphical representations of the percentage of macrophage numbers at each time point for trachea and lungs,
respectively. Error bars represent SEM. n¼signiﬁcant increase when compared to uninfected controls at 12, 24, and 48 hpi in the lungs and nn¼signiﬁcant increase when
compared to all other time points in the trachea.
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Discussion
In this study we investigated the innate immune response
following infection with a virulent strain of IBV Conn A5968 in the
trachea and lungs of chickens. Our ﬁndings in this study are four-fold.
Firstly, we saw that the increased expression of tested TLRs and
downstream signaling molecules that indicates initiation of the
innate host response. Secondly, we saw that the macrophage
numbers are increased in the trachea and lungs, peaking at 24 h
following IBV infection. Finally, we also observed a down-regulation
in the expression of some innate immune genes, TLR3, IL-1β and
IFN-γ, which occurred in the early phase of viral replication (12 hpi).
Altogether, we observed that although the innate response was
initiated early following IBV infection with some genes being
down-regulated, it may not be adequate for the control of viral
replication and associated pathology in the respiratory mucosa.
We observed a signiﬁcant increase of TLR3 relative mRNA
expression in both trachea and lung and TLR7 mRNA expression
only in trachea in IBV infected chickens when compared to the
uninfected controls. Due to the intercalating of the gene encoding
the MyD88 adaptor protein within the pathway activated by TLR7,
we were not surprised to see a similar increase in the expression
of relative MyD88 mRNA as well following IBV infection when
compared to uninfected controls. In avian models such as the
Quingyuan goose (Anser domesticus), correlation between
increased TLR7 and relative MyD88 gene-expression has been
observed (Wei et al., 2013). Surprisingly, there was no signiﬁcant
change in relative TRIF mRNA expression despite the increase in
the relative TLR3 gene expression, which is difﬁcult to explain.
However, a signiﬁcant increase in relative IFN-β gene expression
was observed in trachea at 24 hpi, supporting the previous claims
that the activation of the TLR3 pathway works towards an up-
regulation of IFN-β production in chickens after 12 hpi (Karpala
et al., 2008; Otsuki et al., 1979; Parvizi et al., 2012).
We also noted a signiﬁcant down-regulation in the relative
expression of TLR3, IFN-γ, and IL-1βmRNA during the initial phase
of IBV infection within the trachea when compared to uninfected
controls. Although we did not investigate the viral proteins
involved and the mechanism of down-regulation of host innate
immune molecules in our study, various types of coronaviruses
have been known to encode proteins that disrupt the downstream
signaling cascades used during the innate immune response to
infections (Zhong et al., 2012). The nucelocapsid (N) protein has
been shown to interfere with the 20,50-oligoadenylate synthetase/
RNaseL (20–50 OAS) activation, which is responsible for Type I IFN
induction and can also inhibit the production of various pro-
inﬂammatory cytokines and chemokines via global translational
shutdown (Ye et al., 2007; Zhong et al., 2012). The non-structural
protein 3 (Nsp3) expressed by IBV has also been implicated in de-
ubiquitinating activity, which prevents nuclear translocation and/
or production of the interferon regulatory factor 3 (IRF3) and
sequential synthesis of Type I IFNs (Clementz et al., 2010). In vitro
experiments involving the infection of cell cultures with severe
acute respiratory syndrome coronavirus (SARS-CoV) and IBV
indicate that the interaction of the spike protein found in both
coronaviruses and host eukaryotic initiation factor 3 (eIF3) is
responsible for the modulation of host immune gene expression
(Xiao et al., 2008). However, our study indicated that this initial
down-regulation of innate immune genes is associated with the
increase in IBV replication and the virus induced histological
changes in trachea and lung. Neither Guo et al. nor Wang et al.
observed a down-regulation in expression of the these genes (Guo
et al., 2008; Wang et al., 2006), which could be due to the use of
the less virulent vaccine strains in their studies.
Also, since production of IFN-γ is controlled by cytokines
secreted by both antigen-presenting cells and from the adaptive
arm of immune system, a slight delay in expression is expected in
response to IBV infection (Frucht et al., 2001; Gessani and
Belardelli, 1998; Golab et al., 2000). IL-1β mRNA also showed a
similar down-regulation when compared to uninfected controls in
trachea, but conversely also shows a sharp increase in mRNA
expression as the IBV infection progresses. This is further sub-
stantiated by the observations of Wang et al. and Guo et al., where
both studies found a similar increase in IL-1β expression levels
around 72 hpi with Mass IBV immunization (Guo et al., 2008;
Wang et al., 2006). In contrast, mammalian studies of IL-1β
response to viral infections have been found to be more rapid
than in chickens, with up-regulated gene expression observed as
early as 6 hpi (Lawrence et al., 2013; Poeck et al., 2010).
Macrophage numbers within the lungs and trachea of IBV
infected chickens were found to signiﬁcantly increase when
compared to uninfected controls. In chickens, macrophages are
present within the tissue of the lung itself, lining the atria and
infundibulae and providing a direct line of defence against
respiratory infection (Abdul-Careem et al., 2009; Maina, 2002)
and can be mobilized to the lumen following viral infections
(Cornelissen et al., 2013). Similarly, Fulton and colleagues wit-
nessed macrophage inﬁltration into the respiratory lumen of the
IBV Mass41 infected chickens when collecting respiratory lavage
ﬂuid between 24 and 96 hpi (Fulton et al., 1993). Their study did
not identify the source of these macrophages as trachea and lung
tissues, while our investigation indirectly indicates that macro-
phages may have been mobilised from the parenchyma of both the
trachea and lung following IBV infection.
Conclusions
In conclusion, the results reported here suggest that IBV
infection induces an innate immune response within the respira-
tory tissues through increased mRNA expression of TLR3 and TLR7,
pro-inﬂammatory cytokines and anti-viral IFNs, and an increase in
the number of inﬁltrating macrophages to both the lungs and
trachea, with some of the innate genes being down-regulated
immediately following IBV infection.
Materials and methods
Animals
All procedures have been approved by the University of
Calgary’s Veterinary Sciences Animal Care Committee. Day-old
unsexed speciﬁc pathogen free (SPF) layer chicks (White Leghorn)
were obtained from Canadian Food Inspection Agency, Ottawa,
and raised to 6 days old for use in experiments. The chickens were
not immunized against any diseases. The chickens were housed in
high containment poultry isolators at the University of Calgary’s
Spyhill campus, with ample access to food and water that was
nutritionally complete and appropriate for the age of the chickens.
IBV infection in chickens
Conn A5968 strain of IBV was obtained from ATCC (Manassas,
Virginia, United States). Six day old SPF chickens were infected
with Conn strain of IBV intra-tracheally (2.75104 EID50 per bird)
with controls receiving phosphate buffered saline (PBS). At 12, 24,
48, and 72 h post-infection (hpi), 5–6 IBV infected and 2–5 control
chickens were necropsied and portions of the trachea and lungs
were stored in RNAlater (Qiagen Inc., Mississauga, ON, Canada) at
20 1C for RNA extraction. At the same time points, lung and
trachea were also collected in 10% formol saline (VWR, Edmonton,
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AB, Canada) for the analysis of changes in histology, with IBV (4–5
from each time point) or PBS (2–5 from each time point) treated
groups.
Clinical and pathological observations
The chickens were observed daily for speciﬁc (respiratory
signs) and non-speciﬁc (huddling together, droopy wings and
rufﬂed feathers) clinical signs. Lung and trachea of IBV infected
and control chickens that were preserved in 10% formol saline at
12, 24, 48, and 72 hpi and then sent to the Histopathology
Diagnostic Services Unit at the University of Calgary Faculty of
Veterinary Medicine. The tissues were embedded in parafﬁn,
sectioned at 5 mm, and stained with haematoxylin and eosin. The
histological changes observed in the trachea were scored as
described in (Grgic et al., 2008). The histological changes observed
in lungs were scored based on visible changes in the para-
bronchioles of the lung such as mononuclear cell inﬁltration and
extent of loss of air exchange areas of the lung.
Quantiﬁcation of macrophages from chicken lung and trachea.
Six day old SPF chicks were infected with the Conn IBV strain
(2.75104 EID50 per bird) or treated with PBS. At 12, 24, and
48 hpi the chicks were euthanized and both lungs were collected
in Hank’s balanced salt solution (HBSS) for mononuclear cell
isolation for each of the IBV (n¼3 each time point) and PBS
(n¼3 at each time point) groups. At the same time points, the
tracheas were collected in 0.5 mM EDTA (Ethylenediaminetetra-
acetic acid) in PBS supplemented with 5% heat inactivated fetal
bovine serum (FBS) on ice, for the isolation of cells as described by
Booth and O’Shea (2002), for each of the IBV (n¼5 at each time
point) and PBS (n¼5 at each time point) groups.
RNA extraction and cDNA conversion
RNA was extracted from the trachea and lungs of infected
and uninfected chickens by a single-step method using Trizol
(Invitrogen Canada Inc., Burlington, ON, Canada) according to
the manufacturer’s protocol. RNA concentration was quantiﬁed
using Nanodrop 1000 spectrophotometer at 260 nm wavelength
(Thermo Scientiﬁc, Wilmington, DE, USA). Reverse transcription of
extracted RNA (2000ng) was carried out using 10 RT random
primers (High Capacity cDNA Reverse Transcription Kit, Invitrogen
Life Technologies, Carlsbad, CA) according to the manufacturer’s
instructions. The cDNA product was then diluted with 80 mL of
RNAse-free water to a ﬁnal concentration of 20 ng/mL.
Conventional PCR technique
For absolute and relative quantiﬁcation of the target gene
expression, target and reference genes were PCR-ampliﬁed from
cDNA preparations using primers listed in Table 1, cloned, and
used to generate standard curves. For the preparation of the
standards, relevant fragments were ampliﬁed using standard PCR
conditions.
Preparation of constructs as standards
PCR products were ran at 100 V for 1 h and 15 min on a 1.5%
agarose gel and extracted using QIAquick Gel Extraction Kit
(Qiagen Inc.) according to the manufacturer’s instructions. The
extracted DNA was then cloned into the pCRs2.1-TOPOs vector
and ampliﬁed through transformation of One Shots Escherichia
(E.) coli, followed by blue/white colony screening (TOPO TA
Cloning kit Top 10, Invitrogen, Burlington, ON, Canada). The
subsequently positive white cloned colonies had their plasmids
extracted using the QIAprep spin miniprep kit (Qiagen Inc.), as per
the manufacturer’s instructions. The extracted plasmids were
screened using EcoR1 restriction enzyme (Invitrogen, Burlington,
ON, Canada) and the positive clones were submitted to the
University of Calgary’s Automated DNA Sequencing Services to
be sequenced. The Basic Local Alignment Search Tool (BLAST)
program (NCBI, Bethesda, MD, USA) was used to determine the
accuracy of the target gene insert.
Real-time PCR technique
Real-time PCR technique was used for quantiﬁcation of IBV
genomic RNA and mRNA of host response genes. All the cDNA
Table 1
PCR primers used in conventional and real time PCR techniques.
Primer name Sequence (50–30) Fragment size (Bps) Reference
IBV N F- GACGGAGGACCTGATGGTAA
R- CCCTTCTTCTGCTGATCCTG
206 This study
IFN-α F- ATCCTGCTGCTCACGCTCCTTCT
R- GGTGTTGCTGGTGTCCAGGATG
198 (Villanueva et al., 2011)
IFN-β F- AGCAAGGACAAGAAGCAAGC
R- CGTGCCTTGGTTTACGAAGC
177 (Esnault et al., 2011)
IFN-γ F- ACACTGACAAGTCAAAGCCGCACA
R- AGTCGTTCATCGGGACCTTGGC
129 (Villanueva et al., 2011)
TLR3 F- TCAGTACATTTGTAACACCCCGCC
R- GGCGTCATAATCAAACACTCC
256 (Villanueva et al., 2011)
TLR7 F- TTCTGGCCACAGATGTGACC
R- CCTTCAACTTGGCAGTGCAG
219 (Villanueva et al., 2011)
IL-1β F- GTGAGGCTCAACATTGCGCTGTA
R- TGTCCAGGCGGTAGAAGATGAAG
214 (Villanueva et al., 2011)
iNOS F- GGCAGCAGCGTCTCTATGACTTG
R- GACTTTAGGCTGCCCAGGTTG
185 (St Paul et al., 2013)
MyD88 F- AGCGTGGAGGAGGACTGCAAGAAG
R- CCGATCAAACACACACAGCTTCAG
264 (Villanueva et al., 2011)
TRIF F- GCTCACCAAGAACTTCCTGTG
R- AGAGTTCTCATCCAAGGCCAC
181 (Villanueva et al., 2011)
β-actin F- CAACACAGTGCTGTCTGGTGGTA
R- ATCGTACTCCTGCTTGCTGATCC
205 (Villanueva et al., 2011)
Ubiquitin F- GGGATGCAGATCTTCGTGAAA
R- CTTGCCAGCAAAGATCAACCTT
147 (De Boever et al., 2008)
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preparations originated from IBV infected and control chicken
trachea and lungs were analyzed using qPCR assays, alongside a
dilution series of the plasmids used to generate a standard curve.
Fast SYBRs Green Master Mix (Invitrogen, Burlington, ON, Canada)
containing AmpliTaqs Fast DNA Polymerase was used for this
assay according to the manufacture’s recommendation. In addi-
tion, 5 nM of each of the gene-speciﬁc primers and 9 μL of a 1:10
dilution series of plasmid DNA, or 20 ng of cDNA extracted from
each sample and RNAse-free water were used in the reaction. The
optimum thermal cycling parameters for the IBV genome, TLRs,
interferon, and pro-inﬂammatory cytokines included pre-
incubation at 95 1C for 20 s; 40 cycles of ampliﬁcation/extension
at 95 1C for 3 s, and 60 1C for 30 s; melting curve analysis at 95 1C
for 10 s (Segment 1), 65 1C for 5 s (Segment 2) and 9 1C for 5 s
(Segment 3). Fluorescent acquisition was done at 60 1C for 30 s.
Lung mononuclear cell isolation and trachea total cell isolation
The lungs were rinsed multiple times in HBSS to ensure that
they were free of blood. Using a sterile scalpel and forceps, the
lungs were minced to approximately 5 mm fragments and soaked
in 400 U/mL collagenase type I solution (Sigma-Aldrich, Oakville,
ON, Canada) for 30 min at 37 1C. The trachea was cut into
approximately 5 mm fragments with sterile scissors, suspended
in 0.5 mM EDTA in a 50 mL conical tube, and shook for 20 min at
0.28 g (100 RPM) (41 1C). The dispersed cells and tissue fragments
of both lung and trachea were separated from larger pieces using a
40 mm cell strainer. The trachea required a further processing of
the tissue by grinding with the end of a 3 mL syringe plunger,
followed by washing with 0.5 mM EDTA, for three repetitions in
order to further separate the cells from cartilage and fatty tissue.
The ﬁltered lung cells were pelleted at 233 g for 10 min (4 1C),
followed by re-suspension in HBSS and carefully layered onto 4 mL
Histopaque 1077 (GE Health Care, Mississauga, ON, Canada) in a
15 mL conical tube at room temperature (with a 1:1 ratio of cell
suspension). The layered cells were spun 40 min at 400 g at 20 1C.
The cloudy layer, rich in mononuclear cells, was collected and
pelleted, washed with HBSS. The ﬁltered trachea cells were spun
for 5 min at 500 g at 21 1C, and both the lung and trachea cells
were suspended in complete medium (RPMI medium 1640 sup-
plemented with 2 mM/l L-glutamine, 1% penicillin–streptomycin
and 10% heat inactivated FBS) and the cells were counted.
Flow cytometry technique
Standard ﬂow cytometry procedures were used in the experi-
ments. The cells were stained with 0.5 ug/mL (100 uL) phyco-
erythrin (PE)-labeled mouse anti-chicken KUL01 (Mast et al., 1998),
with an isotype control (SouthernBiotech, Birmingham, Alabama,
USA) or kept as unstained control. The stained samples were
analyzed with a BD LSR II (BD Biosciences, Mississauga, ON, Canada).
Excitation was performed with a 488 nm argon-ion laser and the
emission collected using a 585/42 nm BP ﬁlter for PE conjugates.
Data analyses
Quantiﬁcation of IBV genome loads by real-time PCR was done
by calculating the absolute number of IBV copies per 20 ng of
trachea or lung cDNA, using the standard curve generated by a
serial dilution of plasmids as described previously. The expression
of mRNA of TLR3, TLR7, MyD88, TRIF, iNOS, IL-1β, and IFN-α, -β,
and -γ were calculated using REST 384© (Relative Expression
Software Tool) (Pfafﬂ, 2001; Pfafﬂ et al., 2009; Pfafﬂ et al., 2002;
Pfafﬂ et al., 2004; Vandesompele et al., 2009). The calculation uses
the geometrical mean of Efﬁciency(Eff.)(control)Crossing point (Cp) for
all control genes (β-actin and ubiquitin). FlowJo version 7.6.4
(Ashland, OR, USA) was used to complete the ﬂow cytometry data
visualization and analysis. Except for the REST 384© results, all
data was analyzed using analysis of variance (ANOVA) followed by
Tukey's test to identify differences between observations and
groups using the statistical package, MINITABs release 15 (Minitab
Inc. State College, Pennsylvania, USA). Comparisons were consid-
ered signiﬁcant at Pr0.05.
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